Clinical Trial Update: Efficacy and Safety of Losartan in Children With Ig A Nephropathy [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating efficacy and safety of losartan in children with IgA nephropathy (IgA glomerulonephritis) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glomerulonephritis
• Iga Nephropathy

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Glomerulonephritis, IGA | Phase 3 | Status: COMPLETED